News

Following a transition phase, Evonik is expected to produce the catalysts in Hanau (Germany). The Amperkat brand comprises activated metal catalysts-known as skeletal catalysts and customised supported catalysts.

Myriad’s Prolaris is a molecular diagnostic assay that offers urologists a more accurate way of determining a prostate cancer patient’s risk of recurrence. The new molecular diagnostic test

HalcyGen said that following a pre-registration meeting with the regulatory body it plans to file for registration in the UK in August 2010 as a first step towards

GeoPharma has also indicated that, based on the adequacy of its written response, it is acceptable to manufacture upon FDA approval of its Cephalexin ANDA. Mihir Taneja, CEO

Inovio is co-developing VGX-3400 with Korea-based VGX International. The 30-patient three-dose Phase I study will be conducted in multiple clinical research sites in Korea. A parallel study in

PPD said that the facility expands its global scientific expertise, laboratory capacity and supplies network to meet growing client demand in Europe, Middle East and Africa for these

According to the agreement, the proposed project will encompass a space of approximately 50,000sqmt and mainly focuses on the production, distribution, and research and development of biomedical products.

The trial involved 11 of Synexus’ 26 dedicated recruitment centres across the UK, Europe and South Africa. There were nine US sites also taking part. Of the 565

The project is scheduled to run for 24 months, with the first 12 months committed to experimental research and the second 12 months to selection of a lead